NRG Therapeutics attracts a further £16m to develop treatments that could slow Parkinson's Date 9 November 2022 The biotech company NRG Therapeutics has received a large investment to continue its drug development project into life-changing new treatments.
Come along to a free Me, My Brain and I exhibition or workshop in Piccadilly Circus this weekend Date 28 October 2022 Join us in Piccadilly Circus for free workshops and an exhibition featuring brain sculptures designed by world renowned artists.
Next steps for landmark stem cell study approved Date 27 October 2022 An international clinical trial looking at using stem cells to treat Parkinson’s has been granted approval to go ahead initially in Sweden.
David Allan, Our Trustee Date 27 October 2022 We’re all deeply saddened by the death of our trustee, David Allan.
Our view on the Chancellor’s Emergency Budget Statement Date 17 October 2022 The new Chancellor, Jeremy Hunt, announced measures that will affect energy costs, household debt, and funding for health and social care services.
2022 Parkinson's UK AGM Date 17 October 2022 The 2022 Parkinson’s UK AGM took place on Saturday 15 October with members hearing about the last year at the charity.
Recycle Week 2022 at Parkinson’s UK Date 17 October 2022 17 to 23 October is Recycle Week 2022. We’re joining in and encouraging everyone to recycle for Parkinson’s UK.
We’re partnering with Enterin to develop a potential new treatment for Parkinson’s dementia Date 13 October 2022 We’re investing £2m in Enterin’s phase 2 clinical trial of its drug ENT-01, a potential treatment for Parkinson’s dementia.
Making progress towards a potential new GDNF trial Date 11 October 2022 Over the last 2 years, Vivifi Biotech has made progress towards a trial that aims to overcome the challenges of the last trial. Now, it’s starting work on the final phase of planning.
Caption Parkinson's UK volunteers and staff meeting with MPs at 2022 party conference Parkinson's UK at the 2022 party conferences Date 6 October 2022 An update on who we met at the Labour and Conservative party conferences
